Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled budesonide in hospitalized COVID-19 pneumonia
2020-001616-18Phase 4Terminated
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of budesonide in coronavirus disease 2019 (COVID-19) and viral pneumonia, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Therapeutic failure. Started Apr 2020; status: terminated.
02
Drugs
budesonide
03
Conditions
coronavirus disease 2019 (COVID-19)viral pneumonia
Beyond the preview
Go deeper on 2020-001616-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001616-18.